Broken String Biosciences
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $19M
Investors
- 6
About Broken String Biosciences
Based in Cambridge, UK, and co-founded by Felix Dobbs (CEO), Simon Reed (CSO), Simon Kerr (Chairperson), and Patrick Van (Senior Scientist) in 2020, Broken String Biosciences Limited operates as a biotechnology company offering a sequencing platform for cell and gene therapies. The company provides a sequencing platform that combines biology, sequencing techniques, bioinformatics, data science, and artificial intelligence to develop genome editing methods, resulting in more efficient and cost-effective cell and gene therapies. Broken String’s core technology is INDUCE-seq™, a DNA break mapping technology that precisely analyzes how genome editors interact with and modify genomes. This technique equips researchers and developers by offering critical insights into genome editing processes, resulting in more efficient and targeted therapeutic development.
Who invested in Broken String Biosciences
6 investors across 2 rounds
See all investors in Broken String Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Broken String Biosciences
Who invested in Broken String Biosciences?
Broken String Biosciences has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Broken String Biosciences raised?
Broken String Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Broken String Biosciences last raise money?
Broken String Biosciences's most recent round on record is a Series A, in Sep 2023.
What does Broken String Biosciences do?
Based in Cambridge, UK, and co-founded by Felix Dobbs (CEO), Simon Reed (CSO), Simon Kerr (Chairperson), and Patrick Van (Senior Scientist) in 2020, Broken String Biosciences Limited operates as a biotechnology company offering a sequencing platform for cell and gene therapies.
Where is Broken String Biosciences headquartered?
Broken String Biosciences is headquartered in Cambridge, UK.
Which VCs invest in companies like Broken String Biosciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Broken String Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Broken String Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.